Skip to menu Skip to content Skip to footer

2023

Conference Publication

Branchioma: A Series of 23 Cases Illustrating Frequent Loss of the Retinoblastoma 1 (Rb1)

Baneckova, Martina, Thompson, Lester, Hyrcza, Martin, Vanecek, Tomas, Grossmann, Petr, Michal, Michael, Hajkova, Veronika, Taheri, Touraj, Rupp, Niels, Suster, David, Lakhani, Sunil, Nikolov, Dimitar Hadzi, Skalova, Alena, Michal, Michal and Agaimy, Abbas (2023). Branchioma: A Series of 23 Cases Illustrating Frequent Loss of the Retinoblastoma 1 (Rb1). 112th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP), New Orleans, LA, United States, 11-16 March 2023. Amsterdam, Netherlands: Elsevier.

Branchioma: A Series of 23 Cases Illustrating Frequent Loss of the Retinoblastoma 1 (Rb1)

2023

Conference Publication

Diff-Quik smears from EBUS TBNA procedures: Evaluating measures of tumour cellularity and feasibility of whole genome sequencing (WGS)

Fielding, David, Dalley, Andrew, Singh, Mahendra, Nandakumar, Lakshmy, Lakis, Vanessa, Chittoory, Haarika, Bashirzadeh, Farzad, Bint, Michael, Pahoff, Carl, Son, Jung, Hodgson, Alan, Sharma, Sowmya, Godbolt, David, Coleman, Kylie, Whitfield, Lenore, Waddell, Nicola, Lakhani, Sunil, Nones, Katia, Hartel, Gunter and Simpson, Peter (2023). Diff-Quik smears from EBUS TBNA procedures: Evaluating measures of tumour cellularity and feasibility of whole genome sequencing (WGS). 26th Congress of the Asian Pacific Society of Respirology Above and Beyond, Seoul, Korea, 17-20 November 2022. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.14433

Diff-Quik smears from EBUS TBNA procedures: Evaluating measures of tumour cellularity and feasibility of whole genome sequencing (WGS)

2023

Journal Article

Phyllodes tumour evidence gaps mapped from the 5th edition of the WHO classification of tumours of the breast

Md Nasir, Nur Diyana, Koh, Valerie Cui Yun, Cree, Ian A., Indave Ruiz, Blanca Iciar, Del Águila, Javier, Armon, Subasri, Fox, Stephen B., Lakhani, Sunil R. and Tan, Puay Hoon (2023). Phyllodes tumour evidence gaps mapped from the 5th edition of the WHO classification of tumours of the breast. Histopathology, 82 (5), 704-712. doi: 10.1111/his.14856

Phyllodes tumour evidence gaps mapped from the 5th edition of the WHO classification of tumours of the breast

2023

Journal Article

Hereditary breast cancer: syndromes, tumour pathology and molecular testing

Sokolova, A, Johnstone, K J, McCart Reed, A E, Simpson, P T and Lakhani, S R (2023). Hereditary breast cancer: syndromes, tumour pathology and molecular testing. Histopathology, 82 (1), 70-82. doi: 10.1111/his.14808

Hereditary breast cancer: syndromes, tumour pathology and molecular testing

2023

Journal Article

Survey of recurrent diagnostic challenges in breast phyllodes tumours

Tan, Benjamin Yongcheng, Fox, Stephen B., Lakhani, Sunil R. and Tan, Puay Hoon (2023). Survey of recurrent diagnostic challenges in breast phyllodes tumours. Histopathology, 82 (1), 95-105. doi: 10.1111/his.14730

Survey of recurrent diagnostic challenges in breast phyllodes tumours

2022

Journal Article

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Geyer, C. E., Garber, J. E., Gelber, R. D., Yothers, G., Taboada, M., Ross, L., Rastogi, P., Cui, K., Arahmani, A., Aktan, G., Armstrong, A. C., Arnedos, M., Balmaña, J., Bergh, J., Bliss, J., Delaloge, S., Domchek, S. M., Eisen, A., Elsafy, F., Fein, L. E., Fielding, A., Ford, J. M., Friedman, S., Gelmon, K. A., Gianni, L., Gnant, M., Hollingsworth, S. J., Im, S. A., Jager, A. ... Cho, Eun Kyung (2022). Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer. Annals of Oncology, 33 (12), 1250-1268. doi: 10.1016/j.annonc.2022.09.159

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

2022

Journal Article

Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours (Nature Communications, (2020), 11, 1, (737), 10.1038/s41467-019-14052-x)

Bhandari, Vinayak, Li, Constance H., Bristow, Robert G., Boutros, Paul C., Aaltonen, Lauri A., Abascal, Federico, Abeshouse, Adam, Aburatani, Hiroyuki, Adams, David J., Agrawal, Nishant, Ahn, Keun Soo, Ahn, Sung-Min, Aikata, Hiroshi, Akbani, Rehan, Akdemir, Kadir C., Al-Ahmadie, Hikmat, Al-Sedairy, Sultan T., Al-Shahrour, Fatima, Alawi, Malik, Albert, Monique, Aldape, Kenneth, Alexandrov, Ludmil B., Ally, Adrian, Alsop, Kathryn, Alvarez, Eva G., Amary, Fernanda, Amin, Samirkumar B., Aminou, Brice, Ammerpohl, Ole ... von Mering, Christian (2022). Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours (Nature Communications, (2020), 11, 1, (737), 10.1038/s41467-019-14052-x). Nature Communications, 13 (1) 7569. doi: 10.1038/s41467-022-32339-4

Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours (Nature Communications, (2020), 11, 1, (737), 10.1038/s41467-019-14052-x)

2022

Journal Article

Author Correction: Inferring structural variant cancer cell fraction (Nature Communications, (2020), 11, 1, (730), 10.1038/s41467-020-14351-8)

Cmero, Marek, Yuan, Ke, Ong, Cheng Soon, Schröder, Jan, Adams, David J., Anur, Pavana, Beroukhim, Rameen, Boutros, Paul C., Bowtell, David D. L., Campbell, Peter J., Cao, Shaolong, Christie, Elizabeth L., Cun, Yupeng, Dawson, Kevin J., Demeulemeester, Jonas, Dentro, Stefan C., Deshwar, Amit G., Donmez, Nilgun, Drews, Ruben M., Eils, Roland, Fan, Yu, Fittall, Matthew W., Garsed, Dale W., Gerstung, Moritz, Getz, Gad, Gonzalez, Santiago, Ha, Gavin, Haase, Kerstin, Imielinski, Marcin ... von Mering, Christian (2022). Author Correction: Inferring structural variant cancer cell fraction (Nature Communications, (2020), 11, 1, (730), 10.1038/s41467-020-14351-8). Nature Communications, 13 (1) 7568. doi: 10.1038/s41467-022-32338-5

Author Correction: Inferring structural variant cancer cell fraction (Nature Communications, (2020), 11, 1, (730), 10.1038/s41467-020-14351-8)

2022

Journal Article

NDRG1 in Cancer: A Suppressor, Promoter, or Both?

Joshi, Vaibhavi, Lakhani, Sunil R. and McCart Reed, Amy E. (2022). NDRG1 in Cancer: A Suppressor, Promoter, or Both?. Cancers, 14 (23) 5739, 1-15. doi: 10.3390/cancers14235739

NDRG1 in Cancer: A Suppressor, Promoter, or Both?

2022

Journal Article

Comprehensive histopathologic and genomic analysis of a novel case of lipoblastoma-like tumour of the vulva demonstrating malignant behaviour

Kutasovic, Jamie R., Nones, Katia, Lakis, Vanessa, Koufariotis, Lambros T., Ferguson, Kaltin, McCart Reed, Amy E., Simpson, Peter T., Lakhani, Sunil R., Mar Fan, Helen, Higgins, Megan, Davies, Janene, Payton, Diane and Taege, Lucinda (2022). Comprehensive histopathologic and genomic analysis of a novel case of lipoblastoma-like tumour of the vulva demonstrating malignant behaviour. Human Pathology Reports, 30 300678, 300678-30. doi: 10.1016/j.hpr.2022.300678

Comprehensive histopathologic and genomic analysis of a novel case of lipoblastoma-like tumour of the vulva demonstrating malignant behaviour

2022

Journal Article

Prospective optimization of endobronchial ultrasound-guided transbronchial needle aspiration lymph node assessment for lung cancer: Three needle agitations are noninferior to 10 agitations for adequate tumor cell and DNA yield

Fielding, David, Dalley, Andrew J., Singh, Mahendra, Nandakumar, Lakshmy, Nones, Katia, Lakis, Vanessa, Chittoory, Haarika, Ferguson, Kaltin, Bashirzadeh, Farzad, Bint, Michael, Pahoff, Carl, Son, Jung Hwa, Hodgson, Alan, Sharma, Sowmya, Godbolt, David, Coleman, Kylie, Whitfield, Lenore, Waddell, Nicola, Lakhani, Sunil R., Hartel, Gunter and Simpson, Peter T. (2022). Prospective optimization of endobronchial ultrasound-guided transbronchial needle aspiration lymph node assessment for lung cancer: Three needle agitations are noninferior to 10 agitations for adequate tumor cell and DNA yield. JTO Clinical and Research Reports, 3 (10) 100403, 100403. doi: 10.1016/j.jtocrr.2022.100403

Prospective optimization of endobronchial ultrasound-guided transbronchial needle aspiration lymph node assessment for lung cancer: Three needle agitations are noninferior to 10 agitations for adequate tumor cell and DNA yield

2022

Journal Article

Modeling brain metastasis by internal carotid artery injection of cancer cells

Lim, Malcolm, Fletcher, Nicholas, Reed, Amy Mccart, Flint, Melanie, Thurecht, Kristofer, Saunus, Jodi and Lakhani, Sunil R. (2022). Modeling brain metastasis by internal carotid artery injection of cancer cells. Journal of Visualized Experiments, 2022 (186) e64216. doi: 10.3791/64216

Modeling brain metastasis by internal carotid artery injection of cancer cells

2022

Journal Article

The increasing importance of pathology in modern clinical trial conduct: OlympiA as a case in point

Kalinowski, Lauren, Viale, Giuseppe, Domchek, Susan, Tutt, Andrew, Lucas, Peter C. and Lakhani, Sunil R. (2022). The increasing importance of pathology in modern clinical trial conduct: OlympiA as a case in point. Pathology, 54 (5), 511-516. doi: 10.1016/j.pathol.2022.05.003

The increasing importance of pathology in modern clinical trial conduct: OlympiA as a case in point

2022

Journal Article

Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer

Saunus, Jodi M., De Luca, Xavier M., Northwood, Korinne, Raghavendra, Ashwini, Hasson, Alexander, McCart Reed, Amy E., Lim, Malcolm, Lal, Samir, Vargas, A. Cristina, Kutasovic, Jamie R., Dalley, Andrew J., Miranda, Mariska, Kalaw, Emarene, Kalita-de Croft, Priyakshi, Gresshoff, Irma, Al-Ejeh, Fares, Gee, Julia M. W., Ormandy, Chris, Khanna, Kum Kum, Beesley, Jonathan, Chenevix-Trench, Georgia, Green, Andrew R., Rakha, Emad A., Ellis, Ian O., Nicolau, Dan V., Simpson, Peter T. and Lakhani, Sunil R. (2022). Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer. npj Breast Cancer, 8 (1) 57, 1-16. doi: 10.1038/s41523-022-00425-x

Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer

2022

Journal Article

N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease

Shewell, Lucy K., Day, Christopher J., Kutasovic, Jamie R., Abrahams, Jodie L., Wang, Jing, Poole, Jessica, Niland, Colleen, Ferguson, Kaltin, Saunus, Jodi M., Lakhani, Sunil R., von Itzstein, Mark, Paton, James C., Paton, Adrienne W. and Jennings, Michael P. (2022). N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease. BMC Cancer, 22 (1) 334, 334. doi: 10.1186/s12885-022-09428-0

N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease

2022

Journal Article

Emerging biomarkers for diagnosis, prevention and treatment of brain metastases—from biology to clinical utility

Kalita-de Croft, Priyakshi, Joshi, Vaibhavi, Saunus, Jodi M. and Lakhani, Sunil R. (2022). Emerging biomarkers for diagnosis, prevention and treatment of brain metastases—from biology to clinical utility. Diseases, 10 (1) 11, 1-14. doi: 10.3390/diseases10010011

Emerging biomarkers for diagnosis, prevention and treatment of brain metastases—from biology to clinical utility

2022

Journal Article

Landscape of epidermal growth factor receptor heterodimers in brain metastases

Lim, Malcolm, Nguyen, Tam H., Niland, Colleen, Reid, Lynne E., Jat, Parmjit S., Saunus, Jodi M. and Lakhani, Sunil R. (2022). Landscape of epidermal growth factor receptor heterodimers in brain metastases. Cancers, 14 (3) 533, 533. doi: 10.3390/cancers14030533

Landscape of epidermal growth factor receptor heterodimers in brain metastases

2022

Journal Article

Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content

Ganesamoorthy, Devika, Robertson, Alan James, Chen, Wenhan, Hall, Michael B., Cao, Minh Duc, Ferguson, Kaltin, Lakhani, Sunil R., Nones, Katia, Simpson, Peter T. and Coin, Lachlan J. M. (2022). Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content. BMC Cancer, 22 (1) 85, 85. doi: 10.1186/s12885-021-09160-1

Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content

2022

Journal Article

Blood-derived extracellular vesicle-associated miR-3182 detects non-small cell lung cancer patients

Visan, Kekoolani S., Lobb, Richard J., Wen, Shu Wen, Bedo, Justin, Lima, Luize G., Krumeich, Sophie, Palma, Carlos, Ferguson, Kaltin, Green, Ben, Niland, Colleen, Cloonan, Nicole, Simpson, Peter T., McCart Reed, Amy E., Everitt, Sarah J., MacManus, Michael P., Hartel, Gunter, Salomon, Carlos, Lakhani, Sunil R., Fielding, David and Möller, Andreas (2022). Blood-derived extracellular vesicle-associated miR-3182 detects non-small cell lung cancer patients. Cancers, 14 (1) 257, 257. doi: 10.3390/cancers14010257

Blood-derived extracellular vesicle-associated miR-3182 detects non-small cell lung cancer patients

2022

Book Chapter

Future role of molecular profiling in small breast samples and personalised medicine

Foong, Samuel Y. F., Simpson, Peter T., Cummings, Margaret C. and Lakhani, Sunil R. (2022). Future role of molecular profiling in small breast samples and personalised medicine. A comprehensive guide to core needle biopsies of the breast. (pp. 895-915) edited by Sandra J. Shin, Yunn-Yi Chen and Paula S. Ginter. Cham, Switzerland: Springer International Publishing. doi: 10.1007/978-3-031-05532-4_23

Future role of molecular profiling in small breast samples and personalised medicine